Invesco Ltd. Accelerate Diagnostics, Inc Transaction History

Invesco Ltd.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.54 - $1.41 $7,409 - $19,346	-13,721 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.4 - $5.15 $334 - $1,230	-239 Reduced 1.71%	13,721 $19,000
Q4 2021 Feb 14, 2022	SELL	$4.27 - $6.97 $1,678 - $2,739	-393 Reduced 2.74%	13,960 $72,000
Q3 2021 Nov 15, 2021	BUY	$5.31 - $8.25 $15,499 - $24,081	2,919 Added 25.53%	14,353 $85,000
Q2 2021 Aug 17, 2021	BUY	$6.81 - $9.23 $77,865 - $105,535	11,434 New	11,434 $92,000
Q2 2019 Aug 14, 2019	SELL	$17.79 - $22.88 $278,200 - $357,797	-15,638 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$11.76 - $22.15 $17,745 - $33,424	1,509 Added 10.68%	15,638 $329,000
Q4 2018 Feb 14, 2019	BUY	$10.42 - $21.94 $147,224 - $309,990	14,129 New	14,129 $162,000

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $179M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.